Pharmala Biotech Holdings Inc. (MDMA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2025 | 08-2024 | 08-2023 | 08-2022 | 08-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 117 | 70 | 53 | 12 | 0 |
| Accounts receivable | -85 | -10 | -116 | 9 | -29 |
| Other Working Capital | -27 | -397 | 377 | 112 | 109 |
| Other Operating Activity | -1,049 | 16 | -654 | -758 | -253 |
| Operating Cash Flow | $-1,044 | $-321 | $-340 | $-625 | $-174 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | N/A | 0 | -3 | -3 |
| Net Acquisitions | N/A | N/A | N/A | 0 | 891 |
| Purchase Of Investment | -1,244 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 344 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -32 | -226 | -507 | -992 | -260 |
| Investing Cash Flow | $-935 | $-226 | $-507 | $-995 | $629 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,528 | 697 | N/A | 0 | 83 |
| Other Financing Activity | 72 | 75 | 189 | 0 | 1,933 |
| Financing Cash Flow | $1,600 | $772 | $189 | $0 | $2,017 |
| Beginning Cash Position | 419 | 195 | 852 | 2,472 | 0 |
| End Cash Position | 40 | 419 | 195 | 852 | 2,472 |
| Net Cash Flow | $-379 | $224 | $-657 | $-1,620 | $2,472 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,044 | -321 | -340 | -625 | -174 |
| Capital Expenditure | -35 | -226 | -507 | -995 | -262 |
| Free Cash Flow | -1,079 | -548 | -846 | -1,620 | -436 |